SWOG clinical trial number
S0432

Phase II Studies of Two Different Schedules and Two Different Doses of the Farnesyl Transferase Inhibitor R115777 (Tipifarnib, Zarnestra�, NSC-702818)for Previously Untreated Acute Myeloid Leukemia (AML) in Patients of Age 70 or Older.

100% Accrual
Accrual
100%
Closed
Phase
100% Accrual
Accrual
100%
Published
Abbreviated Title
Phase II Previously Untreated AML in Patients of Age 70 or Older
Activated
09/15/2004
Closed
02/21/2006
Participants
NCORP, Members, Medical Oncologists, Pathologists, CTSU

Research committees

Leukemia

Treatment

R115777